Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
3 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Considerations for Developing a Reassessment Process: Report from the Canadian Real-World Evidence for Value of Cancer Drugs (CanREValue) Collaboration's Reassessment and Uptake Working Group.
Curr Oncol. 2021 Oct 16;28(5):4174-4183. doi: 10.3390/curroncol28050354.
Curr Oncol. 2021.
PMID: 34677272
Free PMC article.
A Practical Methodology for Disaggregating the Drivers of Drug Costs Using Administrative Data.
Lungu ER, Manti OJ, Levine MA, Clark DA, Potashnik TM, McKinley CI.
Lungu ER, et al. Among authors: potashnik tm.
J Popul Ther Clin Pharmacol. 2017 Sep 1;24(1):16-24. doi: 10.22374/1710-6222.24.1.3.
J Popul Ther Clin Pharmacol. 2017.
PMID: 28186712
Item in Clipboard
Development of a Multi-Criteria Decision Analysis Rating Tool to Prioritize Real-World Evidence Questions for the Canadian Real-World Evidence for Value of Cancer Drugs (CanREValue) Collaboration.
Parmar A, Dai WF, Dionne F, Geirnaert M, Denburg A, Ahuja T, Beca J, Bouchard S, Chambers C, Hunt MJ, Husereau D, Lungu E, McDonald V, Mercer RE, Mitera G, Muñoz C, Naipaul R, Peacock S, Potashnik T, Tadrous M, Takhar P, Taylor M, Trudeau M, Wasney D, Gavura S, Chan KKW.
Parmar A, et al. Among authors: potashnik t.
Curr Oncol. 2023 Mar 28;30(4):3776-3786. doi: 10.3390/curroncol30040286.
Curr Oncol. 2023.
PMID: 37185399
Free PMC article.
Item in Clipboard
Cite
Cite